Annovis Bio Announces Collaboration With Weave Bio On Buntanetap NDA; Expects Phase 3 Alzheimer's Topline Data In March 2027
Share
Why It Matters
Annovis Bio is working with another company on an Alzheimer's medicine. They will share important test results next spring to show if it works.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.